Gender as a risk factor for adverse events to medications
Adverse drug reaction (ADR) increase morbidity and mortality, and therefore increase healthcare costs. An important component of quality assurance monitoring is the establishment of an ADR surveillance programme. One goal of the programme is to minimise ADRs through detection, identification of risk...
Gespeichert in:
| Veröffentlicht in: | Drugs (New York, N.Y.) N.Y.), 1995-07, Vol.50 (1), p.1-6 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 6 |
|---|---|
| container_issue | 1 |
| container_start_page | 1 |
| container_title | Drugs (New York, N.Y.) |
| container_volume | 50 |
| creator | KANDO, J. C YONKERS, K. A COLE, J. O |
| description | Adverse drug reaction (ADR) increase morbidity and mortality, and therefore increase healthcare costs. An important component of quality assurance monitoring is the establishment of an ADR surveillance programme. One goal of the programme is to minimise ADRs through detection, identification of risk groups, establishment of drug treatment guidelines and education. Several characteristics have been suggested as risk factors for the development of adverse events including: advanced age, female sex, history of a previous adverse event, multiple medications, duration of hospital stay, liver disease and renal disease. This review focuses on an individual's sex as a risk factor for adverse reactions to drugs. |
| doi_str_mv | 10.2165/00003495-199550010-00001 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77684015</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77684015</sourcerecordid><originalsourceid>FETCH-LOGICAL-c394t-90bb637a9b9700fae741f5060d445a06cf1e59054bfc5aa5967046b5c715bdad3</originalsourceid><addsrcrecordid>eNqFkFFLwzAQx4Moc04_gpAH8a16aXNJ8yhDpzDwRZ_LNU2gurUz6QZ-ezNX9-rBcdz__ncHP8a4gLtcKLyHFIU0mAljEAEEZHtJnLCpENokGeGUTZOSZ0opfc4uYvzYtwbNhE00liWU-ZSZhesaFzhFTjy08ZN7skMfuE9Jzc6F6LjbuW6IfOj52jWtpaHtu3jJzjytorsa64y9Pz2-zZ-z5eviZf6wzGxh5JAZqGtVaDK10QCenJbCIyhopEQCZb1waABl7S0SoVEapKrRaoF1Q00xY7eHu5vQf21dHKp1G61brahz_TZWWqtSgsB_jUKVShaQJ2N5MNrQxxicrzahXVP4rgRUe7zVH97qiPdXEmn1evyxrROL4-LIM81vxjlFSysfqLNtPNoKVKJEWfwA_jeAZA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16864302</pqid></control><display><type>article</type><title>Gender as a risk factor for adverse events to medications</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>KANDO, J. C ; YONKERS, K. A ; COLE, J. O</creator><creatorcontrib>KANDO, J. C ; YONKERS, K. A ; COLE, J. O</creatorcontrib><description>Adverse drug reaction (ADR) increase morbidity and mortality, and therefore increase healthcare costs. An important component of quality assurance monitoring is the establishment of an ADR surveillance programme. One goal of the programme is to minimise ADRs through detection, identification of risk groups, establishment of drug treatment guidelines and education. Several characteristics have been suggested as risk factors for the development of adverse events including: advanced age, female sex, history of a previous adverse event, multiple medications, duration of hospital stay, liver disease and renal disease. This review focuses on an individual's sex as a risk factor for adverse reactions to drugs.</description><identifier>ISSN: 0012-6667</identifier><identifier>EISSN: 1179-1950</identifier><identifier>DOI: 10.2165/00003495-199550010-00001</identifier><identifier>PMID: 7588082</identifier><identifier>CODEN: DRUGAY</identifier><language>eng</language><publisher>Auckland: Adis International</publisher><subject>Biological and medical sciences ; Drug toxicity and drugs side effects treatment ; Drug-Related Side Effects and Adverse Reactions ; Female ; Hormones - metabolism ; Humans ; Male ; Medical sciences ; Miscellaneous (drug allergy, mutagens, teratogens...) ; Pharmacokinetics ; Pharmacology. Drug treatments ; Risk Factors ; Sex Characteristics</subject><ispartof>Drugs (New York, N.Y.), 1995-07, Vol.50 (1), p.1-6</ispartof><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c394t-90bb637a9b9700fae741f5060d445a06cf1e59054bfc5aa5967046b5c715bdad3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3561854$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7588082$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>KANDO, J. C</creatorcontrib><creatorcontrib>YONKERS, K. A</creatorcontrib><creatorcontrib>COLE, J. O</creatorcontrib><title>Gender as a risk factor for adverse events to medications</title><title>Drugs (New York, N.Y.)</title><addtitle>Drugs</addtitle><description>Adverse drug reaction (ADR) increase morbidity and mortality, and therefore increase healthcare costs. An important component of quality assurance monitoring is the establishment of an ADR surveillance programme. One goal of the programme is to minimise ADRs through detection, identification of risk groups, establishment of drug treatment guidelines and education. Several characteristics have been suggested as risk factors for the development of adverse events including: advanced age, female sex, history of a previous adverse event, multiple medications, duration of hospital stay, liver disease and renal disease. This review focuses on an individual's sex as a risk factor for adverse reactions to drugs.</description><subject>Biological and medical sciences</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Drug-Related Side Effects and Adverse Reactions</subject><subject>Female</subject><subject>Hormones - metabolism</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Miscellaneous (drug allergy, mutagens, teratogens...)</subject><subject>Pharmacokinetics</subject><subject>Pharmacology. Drug treatments</subject><subject>Risk Factors</subject><subject>Sex Characteristics</subject><issn>0012-6667</issn><issn>1179-1950</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkFFLwzAQx4Moc04_gpAH8a16aXNJ8yhDpzDwRZ_LNU2gurUz6QZ-ezNX9-rBcdz__ncHP8a4gLtcKLyHFIU0mAljEAEEZHtJnLCpENokGeGUTZOSZ0opfc4uYvzYtwbNhE00liWU-ZSZhesaFzhFTjy08ZN7skMfuE9Jzc6F6LjbuW6IfOj52jWtpaHtu3jJzjytorsa64y9Pz2-zZ-z5eviZf6wzGxh5JAZqGtVaDK10QCenJbCIyhopEQCZb1waABl7S0SoVEapKrRaoF1Q00xY7eHu5vQf21dHKp1G61brahz_TZWWqtSgsB_jUKVShaQJ2N5MNrQxxicrzahXVP4rgRUe7zVH97qiPdXEmn1evyxrROL4-LIM81vxjlFSysfqLNtPNoKVKJEWfwA_jeAZA</recordid><startdate>19950701</startdate><enddate>19950701</enddate><creator>KANDO, J. C</creator><creator>YONKERS, K. A</creator><creator>COLE, J. O</creator><general>Adis International</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T2</scope><scope>7U1</scope><scope>7U2</scope><scope>7U7</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>19950701</creationdate><title>Gender as a risk factor for adverse events to medications</title><author>KANDO, J. C ; YONKERS, K. A ; COLE, J. O</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c394t-90bb637a9b9700fae741f5060d445a06cf1e59054bfc5aa5967046b5c715bdad3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Biological and medical sciences</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Drug-Related Side Effects and Adverse Reactions</topic><topic>Female</topic><topic>Hormones - metabolism</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Miscellaneous (drug allergy, mutagens, teratogens...)</topic><topic>Pharmacokinetics</topic><topic>Pharmacology. Drug treatments</topic><topic>Risk Factors</topic><topic>Sex Characteristics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>KANDO, J. C</creatorcontrib><creatorcontrib>YONKERS, K. A</creatorcontrib><creatorcontrib>COLE, J. O</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Risk Abstracts</collection><collection>Safety Science and Risk</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Drugs (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>KANDO, J. C</au><au>YONKERS, K. A</au><au>COLE, J. O</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gender as a risk factor for adverse events to medications</atitle><jtitle>Drugs (New York, N.Y.)</jtitle><addtitle>Drugs</addtitle><date>1995-07-01</date><risdate>1995</risdate><volume>50</volume><issue>1</issue><spage>1</spage><epage>6</epage><pages>1-6</pages><issn>0012-6667</issn><eissn>1179-1950</eissn><coden>DRUGAY</coden><abstract>Adverse drug reaction (ADR) increase morbidity and mortality, and therefore increase healthcare costs. An important component of quality assurance monitoring is the establishment of an ADR surveillance programme. One goal of the programme is to minimise ADRs through detection, identification of risk groups, establishment of drug treatment guidelines and education. Several characteristics have been suggested as risk factors for the development of adverse events including: advanced age, female sex, history of a previous adverse event, multiple medications, duration of hospital stay, liver disease and renal disease. This review focuses on an individual's sex as a risk factor for adverse reactions to drugs.</abstract><cop>Auckland</cop><pub>Adis International</pub><pmid>7588082</pmid><doi>10.2165/00003495-199550010-00001</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0012-6667 |
| ispartof | Drugs (New York, N.Y.), 1995-07, Vol.50 (1), p.1-6 |
| issn | 0012-6667 1179-1950 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_77684015 |
| source | MEDLINE; SpringerNature Journals |
| subjects | Biological and medical sciences Drug toxicity and drugs side effects treatment Drug-Related Side Effects and Adverse Reactions Female Hormones - metabolism Humans Male Medical sciences Miscellaneous (drug allergy, mutagens, teratogens...) Pharmacokinetics Pharmacology. Drug treatments Risk Factors Sex Characteristics |
| title | Gender as a risk factor for adverse events to medications |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T20%3A44%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gender%20as%20a%20risk%20factor%20for%20adverse%20events%20to%20medications&rft.jtitle=Drugs%20(New%20York,%20N.Y.)&rft.au=KANDO,%20J.%20C&rft.date=1995-07-01&rft.volume=50&rft.issue=1&rft.spage=1&rft.epage=6&rft.pages=1-6&rft.issn=0012-6667&rft.eissn=1179-1950&rft.coden=DRUGAY&rft_id=info:doi/10.2165/00003495-199550010-00001&rft_dat=%3Cproquest_cross%3E77684015%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16864302&rft_id=info:pmid/7588082&rfr_iscdi=true |